Siga Technologies (SIGA) Capital Expenditures Growth (3y) (2013 - 2024)
Siga Technologies (SIGA) Capital Expenditures Growth (3y) (2013 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | 6.52% |
| 3 | Zoetis | 32.62 Bn | 30.68 Bn | 1.62 Bn | 232.22% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 1.64% |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | 75.58% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn | -5.84% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | 32.64% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | 28.56% |
| 10 | Siga Technologies | 224.84 Mn | 69.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -12.02% |
| Jun 30, 2024 | -41.11% |
| Dec 31, 2021 | -29.39% |
| Jun 30, 2021 | -27.31% |
| Dec 31, 2019 | -94.63% |
| Sep 30, 2019 | 2,621.01% |
| Jun 30, 2019 | -26.02% |
| Mar 31, 2019 | 1.84% |
| Dec 31, 2018 | 17.57% |
| Dec 31, 2017 | 177.29% |
| Jun 30, 2017 | 49.75% |
| Dec 31, 2016 | -64.52% |
| Sep 30, 2016 | -25.99% |
| Jun 30, 2016 | -69.62% |
| Mar 31, 2016 | -68.40% |
| Dec 31, 2015 | -47.95% |
| Sep 30, 2015 | 51.22% |
| Dec 31, 2014 | -74.07% |
| Jun 30, 2014 | -39.11% |
| Mar 31, 2014 | -31.18% |